ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,421.35
0.35%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Dynavax Technologies Corp (DVAX)

  7. Dynavax Technologies Corp (DVAX) Noticias

DVAX Dynavax Technologies Corp

11.55
-0.46 (-3.83%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Dynavax Technologies Corp DVAX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.46 -3.83% 11.55 23:00:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
11.92 11.515 11.97 11.55 12.01
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/6/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202419:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202419:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202419:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202419:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202419:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202419:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202419:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202415:18PRNUSDynavax to Present at Upcoming Investor Conferences
24/5/202415:05EDGAR2Form 8-K - Current report
14/5/202407:30PRNUSDynavax Provides Regulatory Update on sBLA for Four-Dose..
08/5/202415:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202415:05EDGAR2Form 8-K - Current report
08/5/202415:01PRNUSDynavax Reports First Quarter 2024 Financial Results and..
24/4/202415:05PRNUSDynavax to Report First Quarter 2024 Financial Results and..
04/3/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202419:17EDGAR2Form 144 - Report of proposed sale of securities
27/2/202417:54PRNUSDynavax to Present at TD Cowen's 44th Annual Health Care..
22/2/202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202415:01PRNUSDynavax Reports Fourth Quarter and Full Year 2023 Financial..
20/2/202417:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202407:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202419:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202419:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202415:15PRNUSDynavax to Report Fourth Quarter and Full Year 2023..
07/2/202419:41EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202413:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202409:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202417:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202408:05EDGAR2Form 8-K - Current report
08/1/202408:00PRNUSDynavax Announces Preliminary Unaudited Fourth Quarter and..
04/1/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:49EDGAR2Form 144 - Report of proposed sale of securities
03/1/202417:33PRNUSDynavax to Present at the 42nd Annual J.P. Morgan Healthcare..
02/1/202415:58EDGAR2Form 144 - Report of proposed sale of securities
05/12/202318:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:18EDGAR2Form 144 - Report of proposed sale of securities
20/11/202316:04PRNUSDynavax to Present at the 6th Annual Evercore ISI HealthCONx..

Su Consulta Reciente

NASDAQ
DVAX
Dynavax Technologies
TSXV
MRVL
Marvel Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados